• August 27, 2014
    DURHAM, N.C., August 27, 2014 – Zoetis Inc. has obtained a full license from the U.S. Department of Agriculture (USDA) to sell Poulvac® Bron GA 08, the first commercially available vaccine to reduce disease caused by Georgia 2008 (GA 08) Type infectious bronchitis virus (IBV) in poultry.Poulvac® Bron GA 08, a live vaccine, is licensed for vaccination of healthy chickens at one day of age or older as an aid in the reduction of disease caused by GA 08. The vaccine was licensed based on clinicalmore...
  • August 20, 2014
    FLORHAM PARK, N.J., Aug. 20, 2014 — Fostera™ PCV MH — the porcine circovirus (PCV) and Mycoplasma hyopneumoniae (M. hyo) combination vaccine that was built from the ground up by Zoetis — now has the longest demonstrated duration of immunity (DOI) to help protect pigs from porcine circovirus-associated disease (PCVAD) caused by PCV Type 2 (PCV2). The U.S. Department of Agriculture has granted the combination vaccine the extended label claim of at least 23 weeks of protection against PCV2, whichmore...
  • August 20, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 18, in London, UK. Juan Ramón Alaix, Chief Executive Officer of Zoetis, will represent the company and respond to questions from analysts. He is scheduled to present at 6:25 a.m. EDT (11:25 a.m. BST). Investors and other interested parties will be able to access a live audio webcast of the presentation by visitingmore...
  • August 14, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Paul Herendeen as its new Executive Vice President and Chief Financial Officer (EVP & CFO), completing a leadership transition that began in April. Herendeen has spent the last 16 years in CFO roles at health care companies Warner Chilcott and MedPointe, building on a successful career in finance, banking and private equity partnerships. In his role at Zoetis, Herendeen willmore...
  • August 13, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, in New York, N.Y. Juan Ramón Alaix, Chief Executive Officer of Zoetis, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. EDT. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/more...
  • August 5, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced it will hold its inaugural Investor Day for financial analysts on Tuesday, Nov. 18, at the New York Stock Exchange. The event, hosted by Chief Executive Officer Juan Ramón Alaix and other members of the Zoetis executive team, will be used to provide investors with information on the company’s strategy, capabilities and value proposition, as well as the overall animal health industry.more...
  • August 5, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2014. The company reported revenue of $1.2 billion for the second quarter of 2014, an increase of 4% from the second quarter of 2013. Revenue reflected an operational2 increase of 6%, with foreign currency having a negative impact of 2 percentage points. Net income for the second quarter of 2014 was $136 million, or $0.27 per diluted share, anmore...
  • July 31, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) declared a third quarter dividend payable to holders of the company’s common stock of $0.072 per share. The dividend is to be paid on Tuesday, Sept. 2, 2014, to holders of record on Wednesday, Aug. 20, 2014. About Zoetis Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 yearsmore...
  • July 28, 2014
    Zoetis Inc. today announced the introduction of on-farm cattle health screening tests for the dairy industry in China. These tests will enable China’s dairy farmers and veterinarians to rapidly screen cattle on the farm for sub-clinical mastitis and ketosis, two of the leading causes of lost production and poor milk quality in China.  Test results will be available within five minutes, providing a quick, convenient tool to rapidly detect early signs of sub-clinical disease and helpmore...
  • June 30, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (EDT) on Tuesday, August 5, 2014. Chief Executive Officer Juan Ramón Alaix and Senior Vice President of Finance Operations and Acting Chief Financial Officer Glenn David will review second quarter 2014 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting themore...